Additional 340B Resources
Legislative Advocacy
- ASHP Letter of Support for the Closing Loopholes for Orphan Drugs Act (H.R. 4538) [9/27/19]
- ASHP Letter Supporting Bill to Clarify Intent of 340B Program [PDF - 8/15/18]
- ASHP Statement for the Record: House Energy and Commerce Subcommittee on Health Hearing: Opportunities to Improve the 340B Drug Pricing Program" [7/11/18]
- ASHP Statement Effective Administration of the 340B Drug Pricing Program [6/19/19]
- ASHP Testimony: U.S. Senate Health, Education, Labor, and Pensions Committee Hearing: Perspectives on the 340B Drug Pricing Program [3/15/18]
- ASHP Issue Brief: Congress Releases 340B Report Including Potential Legislative Options [1/11/18]
- ASHP Opposes H.R. 4710, a Bill Restricting the 340B Program [1/11/18]
- ASHP Letter of Support for HR 4392 [12/13/17]
- ASHP Supports Closing Loopholes for Orphan Drugs Act [PDF - 9/30/16]
- ASHP Statement: House Energy and Commerce Subcommittee on Health Hearing: Examining the 340B Drug Pricing Program [PDF - 3/24/15]
Regulatory Advocacy
- ASHP and Partners File Amicus Briefs in Case with Novartis [PDF - 06/29/2021]
- ASHP and Partners File Amicus Briefs in Case with Eli Lily [PDF - 06/24/2021]
- ASHP and Partners File Amicus Briefs in Case with Novo Nordisk [PDF - 06/24/2021]
- BREAKING NEWS: ASHP Files Amicus Brief in AstraZeneca and HHS Lawsuit in Support of 340B Program [PDF - 05/05/2021]
- ASHP Joins Joint Letter to HHS Secretary Urging HHS to Enforce 340B Laws [PDF- 08/26/2020]
- ASHP Opposes CMS Proposed 340B Cost Collection Survey [11/29/19]
- ASHP Comments on OPPS Proposed Rule [PDF - 9/30/17]
- ASHP Comments on Draft 340B Omnibus Guidance [PDF - 10/27/15]
- Regulatory Alert-Proposed Guidance: 340B Discount Program [PDF - 8/28/15]
Latest News
- ASHP and Allies Demand That Novartis Discontinue Illegal Drug Pricing Practices [PDF - 1/07/21]
- ASHP and Allies Demand That Novo Nordisk Discontinue Illegal Drug Pricing Practices [PDF - 1/07/21]
- ASHP and Allies Demand That Sanofi Discontinue Illegal Drug Pricing Practices [PDF - 1/07/21]
- ASHP and Allies Demand That Astra Zeneca Discontinue Illegal Drug Pricing Practices [PDF - 1/07/21]
- ASHP and Allies Demand That Eli Lilly Discontinue Illegal Drug Pricing Practices [PDF - 1/07/21]
- ASHP and Allies Demand That United Therapeutics Discontinue Illegal Drug Pricing Practices [PDF - 1/07/21]
- ASHP Disappointed in MedPAC Recommendation to Congress on 340B [1/15/2016]
- ASHP Disappointed in 340B Orphan Drug Court Decision [10/16/2015]
State Advocacy
ADVERTISEMENT